TCF7L2: the biggest story in diabetes genetics since HLA? E. ZegginiM. I. McCarthy Commentary Open access 10 November 2006 Pages: 1 - 4
Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport C. FürnsinnT. M. WillsonB. Brunmair Review 22 November 2006 Pages: 8 - 17
High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study L. PrompersM. HuijbertsN. Schaper Article 09 November 2006 Pages: 18 - 25
Impact of diabetes on haemoglobin levels in renal disease R. RavananJ. R. SpiroR. M. Smith Article 28 November 2006 Pages: 26 - 31
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine A. M. VaisermanB. CarstensenL. V. Mechova Short Communication 09 November 2006 Pages: 32 - 35
Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study R. C. HoogeveenC. M. BallantyneJ. S. Pankow Article 29 November 2006 Pages: 36 - 42
Relationships of maternal and paternal birthweights to features of the metabolic syndrome in adult offspring: an inter-generational study in South India S. R. VeenaS. GeethaC. H. D. Fall Article 02 December 2006 Pages: 43 - 54
Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag health study S. CarlssonK. MidthjellV. Grill Short Communication 10 November 2006 Pages: 55 - 58
Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort J. V. van Vliet-OstaptchoukR. Shiri-SverdlovC. Wijmenga Short Communication 10 October 2006 Pages: 59 - 62
Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population G. R. ChandakC. S. JanipalliC. S. Yajnik Short Communication 09 November 2006 Pages: 63 - 67
An association analysis of the HLA gene region in latent autoimmune diabetes in adults M. DesaiE. ZegginiA. Clark Short Communication 02 December 2006 Pages: 68 - 73
Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet M. FexM. Dekker NitertH. Mulder Article 09 November 2006 Pages: 74 - 83
Increasing uncoupling protein-2 in pancreatic beta cells does not alter glucose-induced insulin secretion but decreases production of reactive oxygen species N. Produit-ZengaffinenN. Davis-LameloiseF. Assimacopoulos-Jeannet Article 28 November 2006 Pages: 84 - 93
Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration S. KrapivnerE. ChernogubovaF. M. van ’t Hooft Article 15 November 2006 Pages: 94 - 102
Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery H. BoonE. E. BlaakL. J. C. van Loon Article 28 November 2006 Pages: 103 - 112
Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects V. B. Schrauwen-HinderlingM. E. KooiP. Schrauwen Article 09 November 2006 Pages: 113 - 120
Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach A. FodorC. HarelE. Karnieli Article 28 November 2006 Pages: 121 - 130
Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice Y. TamuraT. OgiharaH. Watada Article 09 November 2006 Pages: 131 - 141
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia S. L. ConarelloG. JiangB. B. Zhang Article 28 November 2006 Pages: 142 - 150
Committed subcutaneous preadipocytes are reduced in human obesity Y. TchoukalovaC. KoutsariM. Jensen Article 10 November 2006 Pages: 151 - 157
β2-Adrenergic activation increases glycogen synthesis in L6 skeletal muscle cells through a signalling pathway independent of cyclic AMP D. L. YamamotoD. S. HutchinsonT. Bengtsson Article 22 November 2006 Pages: 158 - 167
Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity P. D. MountjoyS. J. BaileyG. A. Rutter Article 09 November 2006 Pages: 168 - 177
The effects of acute hypoglycaemia on memory acquisition and recall and prospective memory in type 1 diabetes R. E. WarrenN. N. ZammittB. M. Frier Article 02 December 2006 Pages: 178 - 185
QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up C. StettlerA. BearthP. Diem Article 10 November 2006 Pages: 186 - 194
Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes L. SaumaN. FranckF. H. Nystrom Article 15 November 2006 Pages: 195 - 201
Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases B. T. HawkinsT. F. LundeenR. D. Egleton Article 02 December 2006 Pages: 202 - 211
Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects S. F. FieldJ. M. M. HowsonJ. A. Todd Research Letter 25 October 2006 Pages: 212 - 213
No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects S. CauchiM. VaxillaireP. Froguel Research Letter 09 November 2006 Pages: 214 - 216
Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non-diabetic subjects: the relationship with ATP binding cassette proteins G5 and G8 and Niemann–Pick C1-like 1 mRNA S. E. LallyD. OwensG. H. Tomkin Letter 11 November 2006 Pages: 217 - 219
Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105–2108 R. F. SchwartzJ. NeuC. Wasserfall Letter 21 November 2006 Pages: 220 - 221
Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721 P. E. Cryer Letter 20 September 2006 Pages: 222 - 224
Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49: 1711–1721 B. Schultes Letter 22 September 2006 Pages: 225 - 226
Comment on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes:a consensus algorithm for the initiation and adjustmentof therapy. A consensus statement from the American Diabetes Association and the European Associationfor the Study of Diabetes. Diabetologia 49:1711–1721 M. PortaM. Trento Letter 28 October 2006 Pages: 227 - 228
Comment on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49: 1711–1721 T. TakamuraA. ShimizuS. Kaneko Letter 23 November 2006 Pages: 229 - 230
Response to comments on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721 D. M. Nathanfor the Consensus Group Letter - author's response 14 November 2006 Pages: 231 - 233
Comment on: Schmidt MI, Duncan BB, Vigo A et al (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096 M. B. SnijderJ. M. DekkerJ. C. Seidell Letter 11 October 2006 Pages: 234 - 236
Response to comment on: Schmidt MI, Duncan BB, Vigo A et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096 M. I. SchmidtB. B. Duncanfor the ARIC Investigators Letter 09 November 2006 Pages: 237 - 238
Comment on: Schmidt MI, Duncan BB, Vigo A et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096 J. R. S. Arch Letter 10 November 2006 Pages: 239 - 240
Comment on: Tseng C-H, Tseng C-P, Chong C-K et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760 T. H.-H. ChenB. J. Boucher Letter 27 October 2006 Pages: 241 - 241
Response to comment on: Tseng C-H, Tseng C-P, Chong C-K et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760 C.-H. Tseng Letter 28 November 2006 Pages: 242 - 243
Type 2 diabetes and cardiovascular risk in the UK south Asian community A. H. BarnettA. N. DixonS. Kumar Erratum 09 November 2006 Pages: 244 - 244